Investor · Boston, MA
Michael S. Wyzga
Open Michael in the network graph →Filings
43
SEC Form D
Connections
251
co-filers
Capital
$120.8M
across filings
Active
Jul 2021
to Jun 2023
Most-connected co-filers (251)
Jose' E. Baselga, Ph.D · Cambridge, MA28 sharedLewis Geffen · BOSTON, MA26 sharedAncile Capital Management LLC · New York, NY23 sharedBrian R. Robertson · Thunder Bay, Ontario, Canada23 sharedAlan W. Marty · Palo Alto, CA23 sharedAnastasios Drivas · Toronto, Ontario, Canada23 sharedStuart A. Miller · Miami, FL22 sharedRichard A. Beckwitt · Miami, FL22 sharedAnthony A. Seijas · Miami, FL22 sharedCheryl A. Baizan · Miami, FL22 sharedJay P. Mantz · Miami, FL22 sharedAdam Singer · Miami, FL22 sharedMark Pocock · Sandy, UT22 sharedJoseph R. Mazzarella · Wallingford, CT22 sharedScott J. Gelley · Miami, FL22 sharedRichard D. Slaven · Dallas, TX22 sharedLiat Heller · Miami, FL22 sharedJeffrey P. Krasnoff · Miami, FL21 sharedThomas M. Skimming · North York, Ontario, Canada21 sharedMark King · Miami, FL21 sharedSean T. Leonard · New York, NY21 sharedJaret D. Perryman · Saint Louis, MO21 sharedFelipe Malbran · Vancouver, British Columbia, Canada21 sharedRialto Capital Management, Llc · Miami, FL21 shared
Recent filings (43)
X4 Pharmaceuticals, IncAug 2025 · 19 co-filers$85.0MX4 Pharmaceuticals, IncAug 2025 · 19 co-filers$85.0MX4 Pharmaceuticals, IncJun 2023 · 34 co-filers$65.0MInvivyd, Inc.Nov 2022 · 23 co-filers$23.7MInvivyd, Inc.Nov 2022 · 23 co-filers$23.7MCAH HOLDINGS, INCOct 2022 · 25 co-filers$7.4MX4 Pharmaceuticals, IncJul 2022 · 36 co-filers$111.5MSoul Ventures Growth Opportunity 4, LLC - Series ASep 2021 · 8 co-filers$9.3MCAH HOLDINGS, INCSep 2021 · 25 co-filers$10.0MSoul Ventures Growth Opportunity 4, LLC - Series DJul 2021 · 6 co-filers$1.4MTvardi Therapeutics, Inc.Jun 2021 · 9 co-filers$75.1MTvardi Therapeutics, Inc.Jun 2021 · 9 co-filers$75.1MMereo Biopharma Group plcJun 2020 · 25 co-filers$70.0MMereo Biopharma Group plcJun 2020 · 25 co-filers$70.0MX4 Pharmaceuticals, Inc.Sep 2018 · 10 co-filers$35.0MAura Biosciences, Inc.Jan 2018 · 25 co-filers$42.3MAura Biosciences, Inc.Nov 2017 · 28 co-filers$11.5MRialto Absolute Partnership I, LPAug 2017 · 15 co-filers$100.6MRialto Real Estate Fund III - Property, LPMay 2017 · 31 co-filersRIALTO SPECIAL SITUATIONS FUND, LPApr 2017 · 31 co-filers$100.0MRialto Real Estate Fund III - Debt, LPApr 2017 · 31 co-filersRialto Capital CMBS Fund IV, LPMar 2017 · 28 co-filers$7.4MMindCare Solutions Group, Inc.Mar 2017 · 30 co-filers$25.5MRIALTO SPECIAL SITUATIONS FUND, LPFeb 2017 · 31 co-filers$100.0MRialto Real Estate Fund III - Debt, LPFeb 2017 · 31 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →